Cite
Prognostic impact of the loss of E-cadherin and de novo expression of N-cadherin at the invasive front of primary and recurrent oral squamous cell carcinoma.
MLA
Hakim, Samer George, et al. “Prognostic Impact of the Loss of E-Cadherin and de Novo Expression of N-Cadherin at the Invasive Front of Primary and Recurrent Oral Squamous Cell Carcinoma.” Frontiers in Oncology, May 2023, pp. 01-15. EBSCOhost, https://doi.org/10.3389/fonc.2023.1151879.
APA
Hakim, S. G., Taubitz, C., Hoppe, S., Steller, D., Rades, D., Ribbat-Idel, J., Alsharif, U., & Falougy, M. (2023). Prognostic impact of the loss of E-cadherin and de novo expression of N-cadherin at the invasive front of primary and recurrent oral squamous cell carcinoma. Frontiers in Oncology, 01-15. https://doi.org/10.3389/fonc.2023.1151879
Chicago
Hakim, Samer George, Clara Taubitz, Steffen Hoppe, Daniel Steller, Dirk Rades, Julika Ribbat-Idel, Ubai Alsharif, and Mohamed Falougy. 2023. “Prognostic Impact of the Loss of E-Cadherin and de Novo Expression of N-Cadherin at the Invasive Front of Primary and Recurrent Oral Squamous Cell Carcinoma.” Frontiers in Oncology, May, 01-15. doi:10.3389/fonc.2023.1151879.